U.S. Food And Drug Administration

• Skip to main content
• Skip to FDA Search
• Skip to in this section menu
• Skip to footer links

Topic Paragraphs See Complete List of FDA Reforms

FDA Seizes 7-OH Opioids to Protect American Consumers

The U.S. Food and Drug Administration, in coordination with the U.S. Department of Justice, announced today that the U.S. Marshals Service seized approximately 73,000 units of 7-hydroxymitragynine (7-OH) products—valued at roughly $1 million—from three firms in Missouri.

Read More

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

Report a Problem with an FDA Regulated Product

Dec 29

FDA Finds Insufficient Data to Determine Safety of PFAS in Cosmetic Products

Dec 19

FDA Grants Two National Priority Vouchers

More Press Announcements Newsroom Meetings Testimony Speeches

Dec 26

Gold Star Distribution Inc., Issues Recall of Certain FDA-Regulated Products in Three States Including Drugs, Devices, Cosmetics, Human Foods, and Pet Foods

Animal & Veterinary, Cosmetics, Dietary Supplements, Drugs, Food & Beverages, Medical Devices

Dec 24

Consumers Supply Distributing, LLC Recalls Country Vet Biscuits for Dogs Due to Possible Salmonella Health Risk

Animal & Veterinary, Food & Beverages

Dec 23

Gregory’s Foods Issues Allergy Alert on Undeclared Peanuts in "Bag Full of Cookies" White Chocolate Macadamia Nut Frozen Cookie Dough

Food & Beverages

More Recalls Market Withdrawals & Safety Alerts Subscribe to the Enforcement Report Mailing List Paragraph Header

FDA Encourages Development of New, Reliable Alternatives to Animal Testing in Sunscreen

FDA strongly encourages companies to continue to develop new, reliable ways to minimize animal testing.

FDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity

The FDA is committed to ensuring data transparency by promoting timely registration and reporting of results information to ClinicalTrials.gov.

FDA Advances Drug Development Innovation by Establishing ISTAND as Permanent Qualification Program

ISTAND supports innovative, science-driven approaches that improve drug development and regulatory decision-making.

View More FDA Voices

Dec 22

Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act

Drugs

Dec 19

Processes and Practices Applicable to Bioresearch Monitoring Inspections

Animal & Veterinary, Biologics, Dietary Supplements, Drugs, Food & Beverages, Medical Devices, Radiation-Emitting Products, Tobacco

Dec 18

Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices

Biologics, Medical Devices, Radiation-Emitting Products

FDA Guidance Search

Jobs at FDA

Inspections and Compliance

MedWatch: Safety Alerts

Science & Research

FDA Organization

Import Program

Warning Letters

Combination Products

Criminal Investigations

Disposal of Unused Medicines

Emergency Preparedness

Back to Top Feedback